* Ocugen Inc OCGN.OQ OCGN.O is expected to show no
change in
quarterly revenue when it reports results on August 8 for the
period ending June 30 2024
*
* LSEG's mean analyst estimate for Ocugen Inc is for a loss
of 5
cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Ocugen Inc
is
$7.00, above its last closing price of $1.22.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Mar. 31 2024 -0.06 -0.06 -0.05 Beat 21
Dec. 31 2024 -0.06 -0.03 Beat 53.8
Jan. 1 0001 -0.07 -0.07 -0.06 Beat 14.3
Jan. 1 0001 -0.07 -0.07 -0.08 Missed -9.1
Mar. -0.11 -0.11 -0.07 Beat 35.2
31 2023
Dec. 31 2022 -0.10 -0.10 -0.10 Met -2
Sep. 30 2022 -0.10 -0.10 -0.10 Met -1.7
Jun. 30 2022 -0.08 -0.08 -0.09 Missed -18.4
This summary was machine generated August 6 at 18:32 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)